<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="species">mouse</item><item key="factors"><item><item key="GSE6909GSM159345"/></item><item><item key="GSE6909GSM159346"/></item><item><item key="GSE6909GSM159347"/></item><item><item key="GSE6909GSM159348"/></item><item><item key="GSE6909GSM159349"/></item><item><item key="GSE6909GSM159350"/></item></item><item key="id">7780</item><item key="pop_total">0</item><item key="platform">6</item><item key="summary_wrapped">alpha2-adrenoceptors are essential presynaptic regulators of norepinephrine release from sympathetic nerves. Previous studies in mice...</item><item key="pubmed_id">17673674</item><item key="geo_gse_id">E-GEOD-6909</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">0</item><item key="sample_count">6</item><item key="tags"><item>cell</item><item>endothelial cell</item><item>genome</item><item>norepinephrine</item><item>placenta</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">transcription-profiling-of-moise-placentae-e105-fr</item><item key="geo_id_plat">E-GEOD-6909_A-AFFY-45</item><item key="name">Transcription profiling of moise placentae (E10.5) from adra2bKO and adra2bWT mutants</item><item key="created">Nov.13, 2014</item><item key="summary">alpha2-adrenoceptors are essential presynaptic regulators of norepinephrine release from sympathetic nerves. Previous studies in mice with targeted deletions in the three alpha2-adrenoceptor genes have indicated that these receptors are essential for embryonic development. In the present study, we searched for the alpha2-adrenoceptor subtype(s) involved in placental development and its molecular mechanism using mice carrying targeted deletions in alpha2-adrenoceptor genes.  Congenic alpha2B-adrenoceptor-deficient mice (Adra2b-/-) developed a defect in fetal and maternal vessel formation in the placenta labyrinth at embryonic day E10.5. This defect was accompanied by reduced endothelial cell proliferation and decreased ERK1/2 phosphorylation levels in Adra2b-/- as compared with Adra2b+/+ placenta. Microarray analysis of wild-type and mutant placentae (maternal genotype Adra2b+/-) revealed 179 genes which were significantly up- or downregulated &gt;1.5-fold in alpha2B-deficient placenta. The type 1 receptor for vascular endothelial growth factor (Flt1), which is coexpressed with alpha2B-adrenoceptors in spongiotrophoblast and giant cells of the placenta, was found to be 2.3-fold upregulated in alpha2B-deficient placenta. Neutralization of Flt1 and its soluble splice variant sFlt1 by a specific antibody in vivo prevented the vascular defect in alpha2B-deficient placenta at E10.5. Thus, alpha2B-adrenoceptors are essential to suppress antiangiogenic (s)Flt1 in spongiotrophoblasts to control the coordinated formation of a vascular labyrinth of fetal and maternal blood vessels in the murine placenta during development. Experiment Overall Design: Comparative transcriptome analysis was determined using the GeneChip Mouse Genome 430 2.0 Array (Affymetrix, Santa Clara, CA, USA). Six microarrays from three wild-type and three adra2b deficient mice were performed.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-6909</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-6909/samples/</item></data></biogps>
